Open access · CC-BY
via OpenAlex
Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine
Michele Dal Bo, Marta Gambirasi, Idris Vruzhaj, Erika Cecchin, Abbas Pishdadian, Giuseppe Toffoli, Amin Safa
International Journal of Molecular Sciences · 2025 · ▲ 7 citations
Abstract
Aging is characterized by a progressive deterioration in physiological function and an increased susceptibility to age-related diseases, such as cancer. Monoclonal antibodies (mAbs) constitute a novel therapeutic approach aimed at addressing aging mechanisms such as cellular senescence(definition), inflammaging(definition), and immunosenescence. This text presents an overview of mAb methods aimed at the markers of aging and their potential application in cancer treatment. The mAbs can be categorized into senolytics(definition), senescence-associated secretory phenotype (SASP) neutralizers, and immune checkpoint inhibitors, each targeting fewer aging-related pathways relevant to cancer therapeutic enhancement than the last. Translating promising preclinical evidence into enhanced efficacy and safety in cancer therapy presents challenges, particularly in older populations. This study examines the therapeutic efficacy of mAbs in the treatment of cancer and age-related disorders, focusing on their current and future roles in oncology practice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms26114982
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Bo, M.D., Gambirasi, M., Vruzhaj, I., Cecchin, E., Pishdadian, A., Toffoli, G., & Safa, A. (2025). Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms26114982
Vancouver
Bo MD, Gambirasi M, Vruzhaj I, Cecchin E, Pishdadian A, Toffoli G, et al. Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26114982.
BibTeX
@article{michele2025Target,
title = {Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine},
author = {Michele Dal Bo and Marta Gambirasi and Idris Vruzhaj and Erika Cecchin and Abbas Pishdadian and Giuseppe Toffoli and Amin Safa},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26114982},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Central Asian Journal of Medical Hypotheses and Ethics 2025
Open access · CC-BY
SENOLYTICS AND SENOMORPHICS: A NEW CLASS OF DRUGS FOR ANTI-AGING THERAPY
Acta Materia Medica 2023
Open access · CC-BY
Aging and cancer hallmarks as therapeutic targets
Signal transduction and targeted therapy 2026
Open access · OA
Aging and cancer: current understandings and future perspectives.
Frontiers in aging 2026
Open access · OA
Accelerated biological aging: the role of chronic inflammation, weathering and novel therapeutic strategies.
Frontiers in Cell and Developmental Biology 2022
Open access · CC-BY
Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential
Current Medicinal Chemistry 2026
Citation only